Research and Development

Showing 15 posts of 9603 posts found.

Amsterdam UMC’s new drug doubles remission rates in patients with ulcerative colitis

July 4, 2023 Research and Development Amsterdam UMC, Gastrointestinal tract, mirikizumab, ulcerative colitis

A new drug, being investigated by Amsterdam UMC along with colleagues at various universities, has been shown to be effective …
brainss

Sosei Heptares announces first subject dosed in phase 1 trial for schizophrenia therapy

July 3, 2023 Research and Development HTL'149, Neurology, Sosei Heptares, clinical trial, schizophrenia

Sosei Heptares has announced that it has dosed its first patient in its phase 1 trial evaluating HTL0048149 (HTL’149), a …

Astellas establishes open innovation hub for tumour microenvironment research

June 29, 2023 Research and Development Astellas Pharma, Mitsui Fudosan, Oncology, open innovation hub, tumour microenvironment

Astellas Pharma and Mitsui Fudosan have announced that Astellas plans to establish a tumour microenvironment (TME) open innovation hub, intended …

Anavex Life Sciences and Partex NV Group announce AI-based strategic partnership to enhance patient experience

June 28, 2023 Research and Development AI, Anavex Life Sciences, Partex NV Group, Pharmacy, patient experience

US-based clinical-stage biopharmaceutical company Anavex Life Sciences and German digital pharma platform Partex NV Group have announced a strategic partnership …
markus-spiske-dnbtfbnqlrc-unsplash_1

GSK receives FDA Fast Track designation for novel gonorrhoea vaccine

June 27, 2023 Research and Development FDA, GSK, Infections and infestations, Vaccine, fast track designation, gonorrhoea

GSK has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for its investigational vaccine …
lungs

Verona Pharma submits FDA New Drug Application for COPD treatment

June 27, 2023 Research and Development COPD, Cardiology, FDA, ensifentrine, new drug application, verona pharma

UK-based Verona Pharma has announced that it has submitted a New Drug Application (NDA) to the US Food and Drug …
blood-1813410_960_720

Sanofi shares data about new drug for haemophilia A in paediatric patients

June 26, 2023 Research and Development Haematology, Sanofi, clinical trial, haemophilia a

Sanofi has shared new data from the phase 3 XTEND-Kids study which assessed Altuviiio (Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein) …
dna-1903319_960_720

Cartesian Therapeutics announces successful trial of RNA cell therapy in autoimmunity

June 23, 2023 Research and Development Cartesian Therapeutics, Neurology, RNA, autoimmune, neurology

Clinical stage biotechnology company, Cartesian Therapeutics, has announced results from its clinical trial using RNA CAR T (rCAR T) therapy …
study_participant_receives_niaid-gsk_candidate_ebola_vaccine

Moderna files for FDA authorisation for updated COVID-19 vaccine

June 23, 2023 Research and Development COVID-19, FDA, Immunology, Moderna, Vaccine

Biotechnology company Moderna has announced that it has completed submission of a regulatory application to the US Food and Drug …
inhaler-2520472_960_720

Lupin Healthcare launches Beclu carbon neutral inhalers for asthma treatment

June 22, 2023 Research and Development Asthma & COPD, Beclu, Lupin Healthcare, asthma, carbon neutral, inhaler

UK-based subsidiary of Lupin Limited, Lupin Healthcare, has announced the UK launch of its carbon neutral pressurised metered dose inhalers …

Hyloris enrols first patient in four-arm clinical trial

June 22, 2023 Research and Development Genito-Urinary system, Hyloris, bladder pain, clinical trial, cystitis

Belgian specialty biopharmaceutical company Hyloris has announced that it has enrolled the first patient in its four-arm interstitial cystitis/bladder pain …
mufid-majnun-cm1au42fnrg-unsplash_3

GSK shares positive data for RSV vaccine

June 21, 2023 Research and Development GSK, Immunology, RSV, Vaccine, clinical trial

GSK have announced new positive data from the AReSVi-006 phase 3 trial which assessed the efficacy of a single dose …

Sirnaomics advances isSCC candidate into late-stage clinical development

June 20, 2023 Research and Development FDA, Oncology, Sirnaomics, clinical trial, isSCC

Global RNA therapeutics biopharmaceutical company Sirnaomics has announced that it has advanced its Squamous Cell Carcinoma in situ (isSCC) candidate …

Scientists develop 3D printed pills for time-controlled release

June 19, 2023 Research and Development 3d printed pills, 3d printing, Max Planck Insititute, Pharmacy, University of California

A team of scientists at the Max Planck Institute (MPI) for Informatics, Germany, and the University of California, US, have …

Vaxxas opens manufacturing facility for needle-free vaccine patch

June 19, 2023 Research and Development Immunology, Vaxxas, manufacturing, needle-free vaccines, vaccines

Clinical stage biotech company Vaxxas has announced that it is opening a biomedical manufacturing facility in Brisbane, Australia, for the …
The Gateway to Local Adoption Series

Latest content